Dr Antonio M Abreu-ramos, MD in Essex, MD - Medicare

Dr Antonio M Abreu-ramos, MD is a medicare enrolled "Physical Medicine & Rehabilitation" physician in Essex, Maryland. His current practice location is 1 Eastern Blvd, Essex, Maryland. You can reach out to his office (for appointments etc.) via phone at (410) 574-1400.

Dr Antonio M Abreu-ramos is licensed to practice in Maryland (license number D0076607.) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1861429409.

Contact Information

	Dr Antonio M Abreu-ramos, MD
	1 Eastern Blvd, Essex, MD 21221-7016
	(410) 574-1400
	Not Available

Physician's Profile

Full Name	Dr Antonio M Abreu-ramos
Gender	Male
Speciality
Experience	Years
Location	1 Eastern Blvd, Essex, Maryland
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Antonio M Abreu-ramos attended and graduated from in

NPI Data:

NPI Number: 1861429409
Provider Enumeration Date: 06/27/2006
Last Update Date: 10/30/2015

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Dr Antonio M Abreu-ramos such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1861429409	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208100000X	Physical Medicine & Rehabilitation	D0076607. (Maryland)	Primary
208100000X	Physical Medicine & Rehabilitation	15909 (Puerto Rico)	Secondary
2081S0010X	Physical Medicine & Rehabilitation - Sports Medicine	15909 (Puerto Rico)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Antonio M Abreu-ramos is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Antonio M Abreu-ramos, MD 401 N Michigan Ave, Suite 1200, Chicago, IL 60611-4264 Ph: (312) 635-0973	Dr Antonio M Abreu-ramos, MD 1 Eastern Blvd, Essex, MD 21221-7016 Ph: (410) 574-1400

News Archive

MetLife Foundation Awards for Medical Research presented at AAIC 2015

At the Alzheimer's Association International Conference 2015 in Washington D.C., MetLife Foundation presented its annual MetLife Foundation Awards for Medical Research. These awards were presented to Randall Bateman, M.D., and Christian Haass, Ph.D., for their contributions in advancing Alzheimer's disease research.

ARC Pharmaceuticals granted new U.S. patent

ARC Pharmaceuticals Inc. (ARC) announced today that The University of British Columbia (UBC) has been granted a new US patent entitled "Pharmaceutical Compositions and Methods Relating to Fucans, No. 6,812,220.

Scientists say worst year to be alive was 536 AD

Human history has seen its ups and downs and researchers have questioned the worst year for humans to be alive in. It could be the years of the flu pandemic or that of the Black Death or even the years of the Holocaust.

Study: More than 20% of nursing homes in the U.S. still report staff, PPE shortages

Nearly half of all COVID-19 deaths in the United States have occurred among nursing home residents, whose age, chronic medical conditions, and congregate living quarters place them and their caregivers at high risk of contracting the disease.

CD74 can serve as prognostic marker for colorectal cancer

CD74 is a protein that is expressed in and on cells of the immune system, such as B lymphocytes and antigen presenting cells. This protein is known for its function in facilitating antigen presentation enabling the immune response. Additionally, Professor Shachar's lab has previously shown that CD74 serves as a survival receptor on cells of the immune system, and that its stimulation by its natural ligand -migration inhibitory factor (MIF)- prevents apoptosis (self destruction) of these cells. It was shown that CD74 is markedly expressed on numerous tumors - hematologic as well as epithelial, and can serve as a prognostic marker. CD74's expression and function on colon intestinal epithelial cells is controversial.

Dr Antonio M Abreu-ramos, MD - Medicare in Essex, MD